Popular Science25d
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
UPI25d
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
pix1125d
Nose spray to treat depression? FDA approves first-of-its-kind medicine
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...
Daily Mail25d
Why thin-skinned Australians are missing the point on Sam Konstas - and how he can be the best thing to happen to the Ashes for 20 years, writes LAWRENCE BOOTH
Journalistic generalisations, like nostalgia, are not what they used to be. Once, the rule was that two similar things had to happen in quick succession before the fourth estate could declare a ...